Medium-dose ZKY001 eye drops

DRUG2 trials

Sponsors

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

Conditions

Corneal Epithelial DefectCorneal Epithelium Defect

Phase 2

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops

CompletedNCT06209203

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Corneal Epithelium Defect

Start: 2022-08-03End: 2022-11-08Updated: 2025-01-15

ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial

CompletedNCT06213727

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.Corneal Epithelial Defect

Start: 2022-03-15End: 2022-11-14Updated: 2024-01-19